ESHRE/LinkedIn
Sep 10, 2026, 16:18
New Human Reproduction Press Release on Paracetamol Use During Pregnancy – ESHRE
European Society of Human Reproduction and Embryology (ESHRE) shared on LinkedIn:
”New Human Reproduction Press Release.
Researchers in Denmark have found that girls whose mothers took paracetamol during pregnancy had smaller ovaries, fewer ovarian follicles (the structures that contain immature eggs), smaller uteruses and lower levels of reproductive hormones at three months old, according to a study published in Human Reproduction Open, one of the world’s leading reproductive medicine journals.
Read the entire press release here.”
Other articles featuring ESHRE on Fertility News.
-
Sep 10, 2026, 16:35Devyanshi Dixit: What If the Brain and Reproductive System Are Having a Conversation We’re Still Learning to Hear?
-
Sep 10, 2026, 16:30Save the Date for the ISUOG 2027 World Congress
-
Sep 10, 2026, 16:27Sean Lauber: Which Embryo Culture Medium Offers the Best Chance of a Live Birth?
-
Sep 10, 2026, 16:14Devyanshi Dixit: Menstrual Health – The Vital Sign We Still Don’t Measure Properly
-
Sep 10, 2026, 16:13Margaret Cali: Everybody Told Me to Relax, but Nobody Told Me What to Do With the Fear…
-
Sep 10, 2026, 16:09Clare Mansfield: The Deeply Personal Question Flowering Fertility Started With
-
Sep 10, 2026, 16:07Carmen Mair: Stop Buying Fertility Supplements Before You Know What You’re Actually Trying to Correct
-
Sep 10, 2026, 16:03Devyanshi Dixit: Can We Predict Who Will Have Severe Menopause Symptoms?
-
Sep 10, 2026, 15:58Rajeev Agarwal: Is a Normal BMI Enough to Know You’re Metabolically Healthy Before Trying to Conceive?